Work

Deep ECG survival prediction for all-cause mortality under case-mix shift: discrimination, risk underestimation, and recalibration

Year: 2026
Type: article
Abstract: Background Accurate mortality ranking does not establish reliable absolute-risk prediction when the clinical population changes. We examined discrimination, calibration, demographic increment, and recalibration of deep ECG survival prediction under case-mix shift. Methods A five-seed ECG-demographic discrete-time survival ensemble was developed using CODE-15% training (183,689 participants; 6,603 deaths), validation (22,974; 828), and internal-test cohorts (22,959; 825). Cross-release waveform hashing and lagged cross-correlation identified four duplicates in the Chagas-focused SaMi-Trop cohort; their exclusion left 1,627 participants and 104 deaths. The fixed models were assessed at 1 and 2 years using censoring-aware metrics, paired patient bootstrap intervals, training-only Cox references, and fivefold out-of-fold recalibration. Input-sensitivity analyses included patient-level uncertainty and numerically verified integrated gradients. Results The concordance index (C-index) decreased from 0.842 (95% CI 0.829–0.854) internally to 0.797 (0.757–0.836) externally, and 1-year area under the receiver operating characteristic curve (AUROC) decreased from 0.862 to 0.818. External incremental discrimination over ECG-only was unresolved (C-index difference 0.011, − 0.025 to 0.049). At 2 years, mean external predicted mortality was 3.21% vs. 6.27% observed, with calibration-in-the-large 0.703 (0.494–0.899). Out-of-fold intercept-only and intercept-plus-slope recalibration reduced the Brier score from 0.05558 to 0.05337 and 0.05324, respectively. These improvements quantify within-cohort probability accuracy rather than independently validated clinical benefit. Conclusions This study shows that informative ECG-based mortality ranking can coexist with substantial risk underestimation under case-mix shift. Recalibration improved probability accuracy within SaMi-Trop but shared Brazilian acquisition infrastructure, Chagas-related selection, and unresolved cross-release identity linkage limit claims about transportability. Independent validation is needed before calibrated risks can support clinical decisions.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236819462
FWCI:
Cites: 56
Cited by:
Related to: 10